BIOS Actuate Co-Invest I, LP
Director10% Owner

BIOS Actuate Co-Invest I, LP insider trades: Actuate Therapeutics (ACTU) stock buys and sales

Director, Actuate Therapeutics Last trade Jun 27, 2025 3 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
6
Open-market trades
since 2024
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where BIOS Actuate Co-Invest I, LP reports to the SEC

Open-market buys and sales

6 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 27, 2025ACTU↑ Buy$500K
Aug 14, 2024ACTU↑ Buy$3.0M
Aug 14, 2024ACTU↑ Buy$1.0M
Aug 14, 2024ACTU↓ Sell$156K
Aug 14, 2024ACTU↓ Sell$48K
Aug 14, 2024ACTU↓ Sell$21K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ACTU insiders

Open-market trades in the last 12 months

About BIOS Actuate Co-Invest I, LP's insider trades

BIOS Actuate Co-Invest I, LP is a director at Actuate Therapeutics (ACTU). Since Aug 14, 2024, it has reported 3 open-market purchases worth $4.5M and 3 sales worth $225K on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include grants and awards (2 filings), other transactions (1 filing), conversions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACTU insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.